Concepedia

Hun Ju Lee

HJ

84

Publications

4.9K

Citations

36

H-Index

2004

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Dana-Farber Cancer Institute

University of Bologna

Memorial Sloan Kettering Cancer Center

Mayo Clinic in Arizona

Hun Ju Lee is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2004–2024

84

Publications

84

Double hit lymphoma: the <scp>MD A</scp> nderson <scp>C</scp> ancer <scp>C</scp> enter clinical experience

Yasuhiro Oki, Mansoor Noorani, Pei Lin et al. · British Journal of Haematology · 2014 · 361 citations

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087

Robert Chen, Pier Luigi Zinzani, Hun Ju Lee et al. · Blood · 2019 · 326 citations · Full text

Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study

Radhakrishnan Ramchandren, Eva Domingo‐Doménech, Antonio Rueda et al. · Journal of Clinical Oncology · 2019 · 250 citations · Full text

Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma

Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja et al. · Blood Advances · 2020 · 220 citations · Full text

Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial

Michael Wang, Hun Ju Lee, Hubert H. Chuang et al. · The Lancet Oncology · 2015 · 212 citations

, , +6

Rows per page

1–5 of 84